MK0677

ibutamoren · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0677, covering 2015-07-24 to 2015-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) [Phase 2]